CD79A and histiocytic sarcoma: We collected the presence or absence of any HS in our local cohort of 54 PID patients treated with IgP and tested for anti-IgA IgG, and we searched the available literature for single case reports and case series focusing on IgP-HS with regard to the patient’s anti-IgA IgG status.